Celyad Oncology SA
XBRU:CYAD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Celyad Oncology SA
XBRU:CYAD
|
BE |
|
M
|
Marmaris Altinyunus Turistik Tesisleri AS
IST:MAALT.E
|
TR |
|
Inovio Pharmaceuticals Inc
NASDAQ:INO
|
US |
|
B
|
Bank of Tianjin Co Ltd
HKEX:1578
|
CN |
|
J
|
J Taparia Projects Ltd
BSE:538539
|
IN |
|
H
|
HK Acquisition Corp
HKEX:7841
|
HK |
|
Y
|
Yamana Gold Inc
LSE:AUY
|
CA |
|
Lawson Inc
TSE:2651
|
JP |
|
H
|
Hamilton Insurance Group Ltd
NYSE:HG
|
BM |
|
Daohe Global Group Ltd
HKEX:915
|
HK |
|
American Express Co
LSE:0R3C
|
US |
|
Beigene Ltd
HKEX:6160
|
CN |
|
R
|
Revlon Inc
F:RVL1
|
US |
|
Credit Agricole SA
OTC:CRARF
|
FR |
Bankruptcy Probability
Celyad Oncology SA's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Celyad Oncology SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BE |
|
Celyad Oncology SA
XBRU:CYAD
|
13.3m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
384.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
362.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Celyad Oncology SA's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Celyad Oncology SA has total debt of 754k EUR. This includes both short-term (0 EUR) and long-term (754k EUR) debt.
You can find a full breakdown on its Balance Sheet.
